CHAMPS: A randomized trial of a Community Health Worker intervention for persons living with HIV in two high priority settings
CHAMPS:社区卫生工作者在两个高度优先环境中对艾滋病毒感染者进行干预的随机试验
基本信息
- 批准号:10269043
- 负责人:
- 金额:$ 72.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-25 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountabilityAddressAdherenceAdultAlabamaAnxietyAreaCaringCase ManagementCenters for Disease Control and Prevention (U.S.)ChronicCommunity Health AidesContinuity of Patient CareControl GroupsCountryCountyDataDeep SouthDevelopmentDiagnosisEpidemicEvaluationEvidence based interventionExpectancyFutureGeographic LocationsGoalsHIVHealthHealth InsuranceHealth Services AccessibilityHealthcareHealthcare SystemsHuman immunodeficiency virus testInformal Social ControlInterventionLeadLife ExpectancyLinkLiteratureLocationMediatingMediator of activation proteinMedicalMental DepressionModelingMonitorMotivationNew York CityOutcomeOutcome StudyPersonsPharmaceutical PreparationsPrincipal InvestigatorProviderRandomizedRandomized Controlled TrialsReach, Effectiveness, Adoption, Implementation, and MaintenanceRegimenReproducibilityResearchResourcesSample SizeSecureSelf EfficacySelf ManagementSiteState GovernmentStigmatizationSystemTestingTheoretical modelTimeUnited StatesUnited States Agency for Healthcare Research and QualityViralWorkantiretroviral therapybaseclinical efficacycomparison groupethnic minority populationexperienceimplementation determinantsimprovedinnovationmHealthmedication compliancemobile applicationmotivational enhancement therapypillprimary outcomeracial and ethnicrandomized trialresponsescale upsecondary outcomeskillssocial stigmastandard of caresubstance usesuccesstherapy adherencetool
项目摘要
Despite efforts to achieve UNAIDS 95-95-95 targets, marked deficits remain in HIV testing, antiretroviral
therapy (ART) adherence, and viral suppression among a growing number of persons living with HIV (PLWH).
Gaps in HIV treatment success are particularly pronounced in the United States (US) South and Northeast,
specifically, Alabama (AL) and New York City (NYC), the two high priority settings for our study. These
suboptimal HIV-related health outcomes occur at a time when clinicians have limited time and the US
healthcare system remains fragmented, exacerbating the challenges inherent in the lives of poor or stigmatized
groups, such as PLWH. Therefore, the development and evaluation of interventions using a resource-savvy
cadre of community health workers (CHW) holds promise for addressing these challenges. Yet, gaps exist in
the CHW literature, and research is needed to bring CHW interventions to scale and to ameliorate the large
gaps in the US HIV Care Continuum, particularly in Ending the HIV Epidemic (EHE) priority locations. In
response, our highly experienced study team will address limitations in current research focused on CHW
interventions to improve viral suppression and ART adherence. We propose to build on our strong preliminary
data and directly respond to RFA-NR-20-002 by strengthening our CHW intervention, Birmingham Access to
Care (BA2C), through the use of our existing mobile health (mHealth) approach, WiseApp. The literature and
our preliminary work support the scientific premise that the addition of WiseApp to the CHW intervention
guided by a rigorous theoretical model of supportive accountability will allow PLWH to be better able to self-
manage their ART regimens while CHW monitor their ART adherence in real-time. This will ultimately lead to
an improvement in viral suppression and ART adherence. The proposed study blends the strengths of the
BA2C and WiseApp interventions to test a rigorous and reproducible CHW intervention, Community Health
Workers And MHealth to ImProve Viral Suppression (CHAMPS), to improve viral suppression and ART
adherence. The proposed study will test the intervention’s clinical efficacy and assess implementation factors
through the following specific aims with virally unsuppressed adult PLWH (n=150 in AL and 150 in NYC): 1
Conduct a randomized controlled trial (RCT) to assess the efficacy and sustainability of CHAMPS on viral
suppression (primary outcome) and ART adherence (secondary outcome) compared to the standard of care
(standard of care, control group) over 6 and 12 months. 2) Identify mediators (self-efficacy, motivation
expectancies, self-regulation skills, HIV-related stigma) and moderators (depression, anxiety, substance use)
of CHAMPS on study outcomes. 3) Guided by the Reach Effectiveness Adoption Implementation Maintenance
(RE-AIM) framework, identify multi-level factors associated with successful implementation of CHAMPS to
inform future implementation and scale-up of CHAMPS. Findings from this study will inform the use of CHW
and enhanced mHealth practices to improve the HIV Care Continuum in the US.
尽管为实现艾滋病规划署1995 - 1995 - 1995年的目标作出了努力,
越来越多的艾滋病毒感染者(PLWH)坚持抗逆转录病毒疗法(ART)和抑制病毒。
艾滋病毒治疗成功的差距在美国南部和东北部特别明显,
特别是亚拉巴马(AL)和纽约市(NYC),这是我们研究的两个高优先级环境。这些
当临床医生的时间有限时,
卫生保健系统仍然支离破碎,加剧了穷人或受歧视者生活中固有的挑战
如PLWH。因此,开发和评估干预措施,
社区卫生工作者(CHW)的骨干队伍为应对这些挑战带来了希望。然而,差距存在于
CHW文献和研究需要使CHW干预规模化,并改善大的
美国艾滋病毒护理连续体的差距,特别是在结束艾滋病毒流行(EHE)的优先位置。在
作为回应,我们经验丰富的研究团队将解决目前专注于CHW研究的局限性
干预措施,以改善病毒抑制和ART依从性。我们建议建立在我们强大的初步
数据,并通过加强我们的CHW干预直接回应RFA-NR-20-002,伯明翰
通过使用我们现有的移动的健康(mHealth)方法WiseApp,提供医疗保健(BA 2C)。文献和
我们的初步工作支持科学前提,即在CHW干预中加入WiseApp
在严格的支持性问责理论模型的指导下,将使艾滋病毒携带者能够更好地自我管理,
管理他们的抗逆转录病毒治疗方案,同时CHW实时监测他们的抗逆转录病毒治疗依从性。这将最终导致
病毒抑制和ART依从性的改善。拟议的研究融合了
BA 2C和WiseApp干预措施,以测试严格和可重复的CHW干预措施,社区卫生
Workers And MHealth to ImProve Viral Suppression(CHAMPS),改善病毒抑制和ART
坚持。拟议的研究将测试干预措施的临床疗效,并评估实施因素
通过以下特定目标,对病毒未抑制的成人PLWH(AL组n=150,NYC组n = 150)进行治疗:1
开展随机对照试验(RCT),评估CHAMPS对病毒性
与标准治疗相比,抑制(主要结局)和ART依从性(次要结局)
(标准治疗,对照组)6个月和12个月。2)确定中介(自我效能、动机
预期、自我调节技能、与艾滋病毒有关的耻辱)和调节因素(抑郁、焦虑、物质使用)
CHAMPS的研究结果。3)以达到有效性采用实施维护为指导
(RE-AIM)框架,确定与成功实施CHAMPS相关的多层次因素,
为今后实施和扩大CHAMPS提供信息。这项研究的结果将为CHW的使用提供信息
并加强移动医疗实践,以改善美国的艾滋病毒护理连续体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David S Batey其他文献
David S Batey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David S Batey', 18)}}的其他基金
Promoting Viral Suppression through the CHAMPS+ Intervention in the Deep South
通过 CHAMPS 干预南部腹地促进病毒抑制
- 批准号:
10819823 - 财政年份:2023
- 资助金额:
$ 72.7万 - 项目类别:
Drive to Zero: Developing a digital cohort to understand the drivers of non-sustained viral suppression in the Deep South
驱向零:开发数字队列以了解南方腹地非持续病毒抑制的驱动因素
- 批准号:
10675270 - 财政年份:2023
- 资助金额:
$ 72.7万 - 项目类别:
Harnessing Social Network Support to Improve Retention in Care and Viral Suppression among Young Black Men in Chicago and Alabama: A Hybrid Type I Effectiveness-Implementation Trial of Project nGage
利用社交网络支持改善芝加哥和阿拉巴马州年轻黑人的护理保留和病毒抑制:nGage 项目的 I 型混合有效性实施试验
- 批准号:
10569099 - 财政年份:2021
- 资助金额:
$ 72.7万 - 项目类别:
Harnessing Social Network Support to Improve Retention in Care and Viral Suppression among Young Black Men in Chicago and Alabama: A Hybrid Type I Effectiveness-Implementation Trial of Project nGage
利用社交网络支持改善芝加哥和阿拉巴马州年轻黑人的护理保留和病毒抑制:nGage 项目的 I 型混合有效性实施试验
- 批准号:
10161462 - 财政年份:2021
- 资助金额:
$ 72.7万 - 项目类别:
Harnessing Social Network Support to Improve Retention in Care and Viral Suppression among Young Black Men in Chicago and Alabama: A Hybrid Type I Effectiveness-Implementation Trial of Project nGage
利用社交网络支持改善芝加哥和阿拉巴马州年轻黑人的护理保留和病毒抑制:nGage 项目的 I 型混合有效性实施试验
- 批准号:
10378666 - 财政年份:2021
- 资助金额:
$ 72.7万 - 项目类别:
CHAMPS: A randomized trial of a Community Health Worker intervention for persons living with HIV in two high priority settings
CHAMPS:社区卫生工作者在两个高度优先环境中对艾滋病毒感染者进行干预的随机试验
- 批准号:
10427397 - 财政年份:2020
- 资助金额:
$ 72.7万 - 项目类别:
CHAMPS: A randomized trial of a Community Health Worker intervention for persons living with HIV in two high priority settings
CHAMPS:社区卫生工作者在两个高度优先环境中对艾滋病毒感染者进行干预的随机试验
- 批准号:
10632026 - 财政年份:2020
- 资助金额:
$ 72.7万 - 项目类别:
CHAMPS: A randomized trial of a Community Health Worker intervention for persons living with HIV in two high priority settings
CHAMPS:社区卫生工作者在两个高度优先环境中对艾滋病毒感染者进行干预的随机试验
- 批准号:
10164175 - 财政年份:2020
- 资助金额:
$ 72.7万 - 项目类别:
Geographic Variability in Time from HIV Diagnosis to Viral Suppression in the Deep South: A Roadmap to Accelerated Treatment Initiation
南方腹地从艾滋病毒诊断到病毒抑制的时间地理差异:加速治疗启动的路线图
- 批准号:
10523522 - 财政年份:2018
- 资助金额:
$ 72.7万 - 项目类别:
Geographic Variability in Time from HIV Diagnosis to Viral Suppression in the Deep South: A Roadmap to Accelerated Treatment Initiation
南方腹地从艾滋病毒诊断到病毒抑制的时间地理差异:加速治疗启动的路线图
- 批准号:
10305677 - 财政年份:2018
- 资助金额:
$ 72.7万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 72.7万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 72.7万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 72.7万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 72.7万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 72.7万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 72.7万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 72.7万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 72.7万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 72.7万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 72.7万 - 项目类别: